Latest Insider Transactions at Revance Therapeutics, Inc. (RVNC)
This section provides a real-time view of insider transactions for Revance Therapeutics, Inc. (RVNC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Revance Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Revance Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 15
2023
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
21,401
-23.63%
|
$727,634
$34.55 P/Share
|
|
May 15
2023
|
Dustin S Sjuts President |
SELL
Open market or private sale
|
Direct |
21,015
-12.12%
|
$714,510
$34.55 P/Share
|
|
May 15
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
70,447
-7.09%
|
$2,395,198
$34.55 P/Share
|
|
May 15
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
21,401
-20.3%
|
$727,634
$34.55 P/Share
|
|
May 03
2023
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,534
+17.49%
|
-
|
|
May 03
2023
|
Julian S Gangolli Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,534
+10.51%
|
-
|
|
May 03
2023
|
Jill Beraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,534
+11.0%
|
-
|
|
May 03
2023
|
Vlad Coric Director |
BUY
Grant, award, or other acquisition
|
Direct |
589
+9.24%
|
-
|
|
May 03
2023
|
Angus C. Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,534
+8.83%
|
-
|
|
May 03
2023
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,534
+17.59%
|
-
|
|
May 03
2023
|
Chris Nolet Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,534
+11.0%
|
-
|
|
May 01
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
3,201
-4.83%
|
$99,231
$31.7 P/Share
|
|
Apr 03
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
3,201
-4.61%
|
$102,432
$32.15 P/Share
|
|
Mar 15
2023
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,967
-2.39%
|
$89,010
$30.65 P/Share
|
|
Mar 15
2023
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
7,330
-13.2%
|
$219,900
$30.65 P/Share
|
|
Mar 15
2023
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,739
-5.11%
|
$112,170
$30.65 P/Share
|
|
Mar 15
2023
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,341
-0.65%
|
$160,230
$30.65 P/Share
|
|
Mar 09
2023
|
Mark J Foley CEO |
SELL
Open market or private sale
|
Direct |
70,390
-7.88%
|
$2,182,090
$31.59 P/Share
|
|
Mar 09
2023
|
Dustin S Sjuts President |
SELL
Open market or private sale
|
Direct |
21,508
-14.79%
|
$666,748
$31.59 P/Share
|
|
Mar 09
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
18,517
-20.18%
|
$574,027
$31.59 P/Share
|
|
Mar 09
2023
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
18,496
-24.98%
|
$573,376
$31.59 P/Share
|
|
Mar 01
2023
|
Vlad Coric Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,195
+50.0%
|
-
|
|
Mar 01
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
3,201
-6.09%
|
$105,633
$33.5 P/Share
|
|
Feb 15
2023
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,085
-3.81%
|
$68,805
$33.21 P/Share
|
|
Feb 15
2023
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,766
-2.89%
|
$91,278
$33.21 P/Share
|
|
Feb 01
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
3,201
-5.53%
|
$108,834
$34.6 P/Share
|
|
Jan 20
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
1,000
-1.7%
|
$31,000
$31.0 P/Share
|
|
Jan 09
2023
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
3,701
-2.01%
|
$99,927
$27.67 P/Share
|
|
Dec 31
2022
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
605
+0.08%
|
$7,260
$12.18 P/Share
|
|
Dec 31
2022
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
605
+0.63%
|
$7,260
$12.18 P/Share
|
|
Dec 31
2022
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
645
+1.02%
|
$7,740
$12.18 P/Share
|
|
Dec 15
2022
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,916
-2.97%
|
$61,236
$21.5 P/Share
|
|
Dec 15
2022
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,557
-2.45%
|
$32,697
$21.5 P/Share
|
|
Oct 13
2022
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
49,274
-6.43%
|
$1,281,124
$26.97 P/Share
|
|
Sep 22
2022
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
175,649
+16.43%
|
-
|
|
Sep 22
2022
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
52,396
+26.48%
|
-
|
|
Sep 22
2022
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
42,349
+31.58%
|
-
|
|
Sep 22
2022
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
42,349
+36.38%
|
-
|
|
Sep 14
2022
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
11,000
-25.76%
|
$297,000
$27.07 P/Share
|
|
Jun 30
2022
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.01%
|
$11,000
$11.75 P/Share
|
|
Jun 30
2022
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
965
+1.5%
|
$10,615
$11.75 P/Share
|
|
Jun 30
2022
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+0.13%
|
$11,000
$11.75 P/Share
|
|
May 04
2022
|
Olivia C Ware Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+31.56%
|
-
|
|
May 04
2022
|
Angus C. Russell Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+15.52%
|
-
|
|
May 04
2022
|
Jill Beraud Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+19.46%
|
-
|
|
May 04
2022
|
Julian S Gangolli Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+18.57%
|
-
|
|
May 04
2022
|
Carey O Connor Kolaja Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+31.75%
|
-
|
|
May 04
2022
|
Chris Nolet Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+19.46%
|
-
|
|
May 04
2022
|
Philip J. Vickers Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,059
+16.93%
|
-
|
|
Mar 15
2022
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,835
-1.85%
|
$27,525
$15.79 P/Share
|